Cargando…
Mesenchymal stem cell therapy ameliorates metabolic dysfunction and restores fertility in a PCOS mouse model through interleukin-10
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrine and metabolic disorder in reproductive-age women. Excessive inflammation and elevated androgen production from ovarian theca cells are key features of PCOS. Human bone marrow mesenchymal stem cells (BM-hMSC) and their secreted...
Autores principales: | Chugh, Rishi Man, Park, Hang-soo, El Andaloussi, Abdeljabar, Elsharoud, Amro, Esfandyari, Sahar, Ulin, Mara, Bakir, Lale, Aboalsoud, Alshimaa, Ali, Mohamed, Ashour, Dalia, Igboeli, Prosper, Ismail, Nahed, McAllister, Jan, Al-Hendy, Ayman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8261924/ https://www.ncbi.nlm.nih.gov/pubmed/34233746 http://dx.doi.org/10.1186/s13287-021-02472-w |
Ejemplares similares
-
Safety of Intraovarian Injection of Human Mesenchymal Stem Cells in a Premature Ovarian Insufficiency Mouse Model
por: Park, Hang-Soo, et al.
Publicado: (2021) -
Mesenchymal Stem Cell-Conditioned Media Regulate Steroidogenesis and Inhibit Androgen Secretion in a PCOS Cell Model via BMP-2
por: Chugh, Rishi Man, et al.
Publicado: (2021) -
Towards Cell free Therapy of Premature Ovarian Insufficiency: Human Bone Marrow Mesenchymal Stem Cells Secretome Enhances Angiogenesis in Human Ovarian Microvascular Endothelial Cells
por: Park, Hang-Soo, et al.
Publicado: (2019) -
Human BM-MSC secretome enhances human granulosa cell proliferation and steroidogenesis and restores ovarian function in primary ovarian insufficiency mouse model
por: Park, Hang-soo, et al.
Publicado: (2021) -
Intraovarian injection of autologous human mesenchymal stem cells increases estrogen production and reduces menopausal symptoms in women with premature ovarian failure: two case reports and a review of the literature
por: Igboeli, Prosper, et al.
Publicado: (2020)